摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Boc-2-aminothiazole | 1519728-58-5

中文名称
——
中文别名
——
英文名称
Boc-2-aminothiazole
英文别名
tert-butyl 2-amino-1,3-thiazole-4-carboxylate
Boc-2-aminothiazole化学式
CAS
1519728-58-5
化学式
C8H12N2O2S
mdl
——
分子量
200.261
InChiKey
HLZDTEQPACMNJR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    13
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    93.4
  • 氢给体数:
    1
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    描述:
    Boc-2-aminothiazole硫光气 生成 Tert-butyl 2-isothiocyanato-1,3-thiazole-4-carboxylate
    参考文献:
    名称:
    Phenylamino isothiazole carboxamidines as MEK inhibitors
    摘要:
    这项发明涉及抑制MEK并具有抗肿瘤活性的化合物。这些化合物包括N-取代-3-羟基-5-芳基氨基异噻唑-4-甲酰胺。还包括互变异噻唑-3(2H)-酮。
    公开号:
    US20060194802A1
点击查看最新优质反应信息

文献信息

  • [EN] IMIDAZOPYRIDINE AND IMIDAZOPYRAZINE COMPOUNDS USEFUL AS KINASE INHIBITORS<br/>[FR] COMPOSÉS D'IMIDAZOPYRIDINE ET D'IMIDAZOPYRAZINE UTILISÉS COMME INHIBITEURS DE KINASE
    申请人:BRISTOL MYERS SQUIBB CO
    公开号:WO2009155388A1
    公开(公告)日:2009-12-23
    A compound of Formula (I) or Formula (II) and enantiomers, diastereomers and pharmaceutically-acceptable salts thereof. Also disclosed are pharmaceutical compositions containing compounds of Formula (I) or Formula (II), and methods of treating conditions associated with the activity of p38 kinase.
    一种由化合物(I)或化合物(II)及其对映体、二对映体和药学上可接受的盐组成的复合物。还公开了含有化合物(I)或化合物(II)的药物组合物,以及治疗与p38激酶活性相关疾病的方法。
  • [EN] MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS<br/>[FR] MODULATEURS DE TRANSPORTEURS DE TYPE CASSETTE DE LIAISON A L'ATP
    申请人:VERTEX PHARMA
    公开号:WO2005075435A1
    公开(公告)日:2005-08-18
    The present invention relates to modulators of ATP-Binding Cassette ('ABC') transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator ('CFTR'), compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators (I) or a pharmaceutically acceptable salt thereof, wherein: Ht is a 5-membered heteroaromatic ring containing 1-4 heteroatoms selected from O, S, N or NH, wherein said ring is optionally fused to a 6-membered monocyclic or 10-membered bicyclic carbocyclic or heterocyclic, aromatic or non-aromatic ring, wherein Ht is optionally substituted with w occurrences of -WRw, wherein w is 0-5; ring A is 3-7 membered monocyclic ring having 0-3 heteroatoms selected from O, S, N, or NH, wherein ring A is optionally substituted with q occurrences of QRQ; ring B is optionally fused to 5-6 membered carbocyclic or heterocyclic, aromatic or non-aromatic ring .
    本发明涉及ATP结合盒('ABC')转运蛋白或其片段的调节剂,包括囊性纤维化跨膜传导调节蛋白('CFTR'),以及相关的组合物和方法。本发明还涉及使用这些调节剂(I)或其药学上可接受的盐治疗ABC转运蛋白介导的疾病的方法,其中:Ht是含有1-4个来自O、S、N或NH的杂原子的5元杂芳环,其中所述环可选择地与含有0-5个-WRw的w出现的6元单环或10元双环碳环或杂环、芳香或非芳香环融合;环A是具有0-3个来自O、S、N或NH的杂原子的3-7元单环,其中环A可选择地与q出现的QRQ取代;环B可选择地与5-6元碳环或杂环、芳香或非芳香环融合。
  • [EN] TRIAZOLOPYRIDINE COMPOUNDS USEFUL AS KINASE INHIBITORS<br/>[FR] COMPOSÉS DE TRIAZOLOPYRIDINE UTILISÉS COMME INHIBITEURS DE KINASE
    申请人:BRISTOL MYERS SQUIBB CO
    公开号:WO2009155389A1
    公开(公告)日:2009-12-23
    A compound of Formula (I) and enantiomers, diastereomers and pharmaceutically-acceptable salts thereof. Also disclosed are pharmaceutical compositions containing compounds of Formula (I), and methods of treating conditions associated with the activity of p38 kinase.
    一种由式(I)的化合物及其对映体、二对映体和药用可接受的盐组成的混合物。还公开了含有式(I)化合物的药物组合物,以及治疗与p38激酶活性相关疾病的方法。
  • [EN] ANTIMICROBIAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME<br/>[FR] COMPOSÉS ANTIMICROBIENS ET PROCÉDÉS DE FABRICATION ET D'UTILISATION DE CEUX-CI
    申请人:MELINTA THERAPEUTICS INC
    公开号:WO2016145417A1
    公开(公告)日:2016-09-15
    The present disclosure relates generally to the field of antimicrobial compounds and to methods of making and using them. These compounds are useful for treating, preventing, reducing the risk of, and delaying the onset of microbial infections in humans and animals.
    本公开涉及抗微生物化合物领域,以及制备和使用这些化合物的方法。这些化合物可用于治疗、预防、降低人类和动物微生物感染的风险,并延缓感染的发生。
  • NOVEL 9-SUBSTITUTED-5-CARBOXY-OXADIAZINO-QUINOLONE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS ANTI-BACTERIALS
    申请人:Ropp Sandrine
    公开号:US20100009980A1
    公开(公告)日:2010-01-14
    A subject of the invention is the compounds of formula (I): wherein R 1 , R 2 , R 3 , R′ 3 , R 4 , R′ 4 , R 5 , R 6 and R 7 are as described in the application, in the form of enantiomers or mixtures, as well as their salts with acids and bases, their preparation and their application as anti-bacterials, in both human and veterinary medicine.
    本发明涉及以下式(I)的化合物:其中R1、R2、R3、R′3、R4、R′4、R5、R6和R7如申请中所述,以对映体或混合物的形式存在,以及它们与酸和碱的盐,它们的制备以及它们作为抗菌剂在人类和兽医医学中的应用。
查看更多